Position in PFE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,230,703
+$168,102 QoQ
Shares Held
51,109
+35.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#1,198
of 2,820 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KELLEHER FINANCIAL ADVISORS holds $17,885,890 across 12 Drug Manufacturers - General names. PFE ranks #7 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
17,508 | $4,405,712 | |
| 2 | JNJ |
Johnson & Johnson
|
12,574 | $3,193,418 | |
| 3 | LLY |
ELI LILLY & Co
|
2,498 | $2,996,175 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
17,214 | $2,174,816 | |
| 5 | AMGN |
Amgen Inc
|
5,256 | $1,903,301 | |
| 6 | MRK |
Merck & Co., Inc.
|
12,663 | $1,627,195 | |
| 7 | PFE |
Pfizer Inc
This page
|
51,109 | $1,230,703 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,625 | $208,872 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,230,703 | 51,109 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,062,601 | 37,842 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $858,326 | 34,471 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $504,707 | 19,808 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,085,782 | 44,793 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,013,498 | 39,996 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $938,021 | 35,357 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $991,744 | 34,269 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $969,814 | 34,661 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $822,121 | 29,626 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $788,442 | 27,386 | Shares | Sole | 2024-04-25 | |
| 2023-09-30 | $829,515 | 25,008 | Shares | Sole | 2024-04-25 | |
| 2023-06-30 | $1,127,799 | 30,747 | Shares | Sole | 2024-04-25 | |
| 2023-03-31 | $1,037,217 | 25,422 | Shares | Sole | 2024-04-25 | |
| 2022-12-31 | $1,562,051 | 30,485 | Shares | Sole | 2024-04-25 | |
| 2022-09-30 | $1,331,923 | 30,437 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,037,534 | 38,862 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,568,216 | 30,292 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,791,458 | 30,338 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $1,956,309 | 45,485 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,193,205 | 30,470 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,051,938 | 29,035 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,031,121 | 28,012 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,049,875 | 28,607 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $934,697 | 28,584 | Shares | Sole | 2021-11-02 | |
| 2020-03-31 | $932,099 | 28,557 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||